Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 453

1.

Long-Term Electrocardiographic Changes and Clinical Outcomes of Transcatheter Aortic Valve Implantation Recipients Without New Postprocedural Conduction Disturbances.

Muntané-Carol G, Alméndarez M, Junquera L, Wintzer-Wehekind J, Del Val D, Faroux L, Delarochellière R, Paradis JM, Dumont E, Kalavrouziotis D, Mohammadi S, Côté M, Philippon F, Rodés-Cabau J.

Am J Cardiol. 2019 Oct 15. pii: S0002-9149(19)31117-8. doi: 10.1016/j.amjcard.2019.09.047. [Epub ahead of print]

PMID:
31732136
2.

2019 Canadian Cardiovascular Society Position Statement for Transcatheter Aortic Valve Implantation.

Asgar AW, Ouzounian M, Adams C, Afilalo J, Fremes S, Lauck S, Leipsic J, Piazza N, Rodes-Cabau J, Welsh R, Wijeysundera HC, Webb JG.

Can J Cardiol. 2019 Nov;35(11):1437-1448. doi: 10.1016/j.cjca.2019.08.011.

PMID:
31679616
3.

Plaque Sealing With Drug-Eluting Stents Versus Medical Therapy for Treating Intermediate Non-Obstructive Saphenous Vein Graft Lesions: A Pooled Analysis of the VELETI and VELETI II Trials.

Maes F, Jolly SS, Cairns J, Delarochellière R, Côté M, Dzavik V, Rodés-Cabau J.

J Invasive Cardiol. 2019 Nov;31(11):E308-E315.

4.

Recurrence of Device-Related Thrombus After Percutaneous Left Atrial Appendage Closure.

Asmarats L, Cruz-González I, Nombela-Franco L, Arzamendi D, Peral V, Nietlispach F, Latib A, Maffeo D, González-Ferreiro R, Rodríguez-Gabella T, Agudelo V, Alamar M, Ghenzi RA, Mangieri A, Bernier M, Rodés-Cabau J.

Circulation. 2019 Oct 22;140(17):1441-1443. doi: 10.1161/CIRCULATIONAHA.119.040860. Epub 2019 Oct 21. No abstract available.

PMID:
31634013
5.

To Turn Over Rocks for Transcatheter Aortic Valve Replacement: Closure Time With Adenosine Diphosphate to Support Decisions in a Complex Transcatheter Aortic Valve-in-Valve Procedure.

Lefebvre-Desjardins M, Alhayja'a RA, Dumont É, Pibarot P, Rodés-Cabau J, Paradis JM.

Can J Cardiol. 2019 Oct;35(10):1419.e17-1419.e20. doi: 10.1016/j.cjca.2019.05.030. Epub 2019 May 31.

PMID:
31601415
6.

Transcatheter closure of patent foramen ovale in patients older than 60 years of age with cryptogenic embolism.

Wintzer-Wehekind J, Alperi A, Houde C, Côté JM, Del Val D, Côté M, Rodés-Cabau J.

Rev Esp Cardiol (Engl Ed). 2019 Oct 1. pii: S1885-5857(19)30216-6. doi: 10.1016/j.rec.2019.07.003. [Epub ahead of print] English, Spanish.

PMID:
31585849
7.

Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation.

Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger-Toller A, Biasco L, Lurz P, Braun D, Brochet E, Connelly KA, de Bruijn S, Denti P, Deuschl F, Estevez-Loureiro R, Fam N, Frerker C, Gavazzoni M, Hausleiter JR, Ho E, Juliard JM, Kaple R, Besler C, Kodali S, Kreidel F, Kuck KH, Latib A, Lauten A, Monivas V, Mehr M, Muntané-Carol G, Nazif T, Nickening G, Pedrazzini G, Philippon F, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Scha Fer U, Schofer J, Sievert H, Tang GHL, Thiele H, Topilsky Y, Rommel KP, Delgado V, Vahanian A, Von Bardeleben RS, Webb JG, Weber M, Windecker S, Winkel M, Zuber M, Leon MB, Hahn RT, Bax JJ, Enriquez-Sarano M, Maisano F.

J Am Coll Cardiol. 2019 Sep 24. pii: S0735-1097(19)37739-3. doi: 10.1016/j.jacc.2019.09.028. [Epub ahead of print]

PMID:
31568868
8.

Coronary Stent Protruding in the Ascending Aorta: Multimodality Imaging Evaluation.

Wintzer-Wehekind J, Larose E, Rodés-Cabau J, Barbeau G.

JACC Cardiovasc Interv. 2019 Sep 21. pii: S1936-8798(19)31716-9. doi: 10.1016/j.jcin.2019.07.052. [Epub ahead of print] No abstract available.

PMID:
31563684
9.

Mitral Valve Disease With Severe Mitral Annulus Calcification: Transcatheter Therapy May Be the Solution.

Rodés-Cabau J, Dagenais F.

J Am Coll Cardiol. 2019 Sep 17;74(11):1441-1443. doi: 10.1016/j.jacc.2019.06.071. No abstract available.

PMID:
31514944
10.

Valve-in-Valve Challenges: How to Avoid Coronary Obstruction.

Bernardi FLM, Dvir D, Rodes-Cabau J, Ribeiro HB.

Front Cardiovasc Med. 2019 Aug 23;6:120. doi: 10.3389/fcvm.2019.00120. eCollection 2019. Review.

11.

New-Onset Left Bundle Branch Block Post-TAVI: No More an Innocent Bystander.

Muntané-Carol G, Philippon F, Rodés-Cabau J.

Can J Cardiol. 2019 Oct;35(10):1286-1288. doi: 10.1016/j.cjca.2019.06.013. Epub 2019 Jun 21. No abstract available.

PMID:
31500887
12.

Complete Revascularization with Multivessel PCI for Myocardial Infarction.

Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendón J, Faxon DP, Mauri L, Rao SV, Feldman L, Steg PG, Avezum Á, Sheth T, Pinilla-Echeverri N, Moreno R, Campo G, Wrigley B, Kedev S, Sutton A, Oliver R, Rodés-Cabau J, Stanković G, Welsh R, Lavi S, Cantor WJ, Wang J, Nakamya J, Bangdiwala SI, Cairns JA; COMPLETE Trial Steering Committee and Investigators.

N Engl J Med. 2019 Oct 10;381(15):1411-1421. doi: 10.1056/NEJMoa1907775. Epub 2019 Sep 1.

PMID:
31475795
13.

Optimizing Valve Implantation Depth to Win the Battle Against Conduction Disturbances Post-TAVR.

Rodés-Cabau J.

JACC Cardiovasc Interv. 2019 Sep 23;12(18):1808-1810. doi: 10.1016/j.jcin.2019.06.039. Epub 2019 Aug 28. No abstract available.

PMID:
31473232
14.

The Atrial Flow Regulator device: expanding the field of interatrial shunting for treating heart failure patients.

Guimarães L, Del Val D, Rodés-Cabau J.

EuroIntervention. 2019 Aug 29;15(5):398-400. doi: 10.4244/EIJV15I5A73. No abstract available.

15.

Early Experience With Transcatheter Mitral Valve Replacement: A Systematic Review.

Del Val D, Ferreira-Neto AN, Wintzer-Wehekind J, Dagenais F, Paradis JM, Bernier M, O'Connor K, Beaudoin J, Freitas-Ferraz AB, Rodés-Cabau J.

J Am Heart Assoc. 2019 Sep 3;8(17):e013332. doi: 10.1161/JAHA.119.013332. Epub 2019 Aug 23.

16.

Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert Panel.

Rodés-Cabau J, Ellenbogen KA, Krahn AD, Latib A, Mack M, Mittal S, Muntané-Carol G, Nazif TM, Sondergaard L, Urena M, Windecker S, Philippon F.

J Am Coll Cardiol. 2019 Aug 27;74(8):1086-1106. doi: 10.1016/j.jacc.2019.07.014. Review.

PMID:
31439219
17.

Initial Experience with the Second-Generation V-Wave Shunt for Treating Patients with Chronic Heart Failure.

Guimarães L, Bergeron S, Bernier M, Rodriguez-Gabella T, Del Val D, Pibarot P, Eigler N, Abraham WT, Rodés-Cabau J.

EuroIntervention. 2019 Aug 20. pii: EIJ-D-19-00291. doi: 10.4244/EIJ-D-19-00291. [Epub ahead of print] No abstract available.

18.

Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation: Insights From the First-in-Human Experience.

Asmarats L, Perlman G, Praz F, Hensey M, Chrissoheris MP, Philippon F, Ofek H, Ye J, Puri R, Pibarot P, Attinger A, Moss R, Bédard E, Moschovitis A, Reineke D, Lauck S, Blanke P, Leipsic J, Spargias K, Windecker S, Webb JG, Rodés-Cabau J.

JACC Cardiovasc Interv. 2019 Aug 12;12(15):1438-1447. doi: 10.1016/j.jcin.2019.04.038.

PMID:
31395213
19.

Surgery for Isolated Tricuspid Regurgitation: Limitations of Observational Analyses.

O'Gara PT, Gillinov M, Rodés-Cabau J.

J Am Coll Cardiol. 2019 Aug 13;74(6):726-728. doi: 10.1016/j.jacc.2019.06.035. No abstract available.

PMID:
31395121
20.

Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement.

Rodriguez-Gabella T, Catalá P, Muñoz-García AJ, Nombela-Franco L, Del Valle R, Gutiérrez E, Regueiro A, Jimenez-Diaz VA, Ribeiro HB, Rivero F, Fernandez-Diaz JA, Pibarot P, Alonso-Briales JH, Tirado-Conte G, Moris C, Diez Del Hoyo F, Jiménez-Britez G, Zaderenko N, Alfonso F, Gómez I, Carrasco-Moraleja M, Rodés-Cabau J, San Román Calvar JA, Amat-Santos IJ.

J Am Coll Cardiol. 2019 Aug 6;74(5):631-641. doi: 10.1016/j.jacc.2019.05.055.

PMID:
31370954
21.

Transcatheter Aortic Valve Replacement With the HLT Meridian Valve.

Rodés-Cabau J, Williams MR, Wijeysundera HC, Kereiakes DJ, Paradis JM, Staniloae C, Saric M, Radhakrishnan S, Wilson RF, Kubo SH.

Circ Cardiovasc Interv. 2019 Aug;12(8):e008053. doi: 10.1161/CIRCINTERVENTIONS.119.008053. Epub 2019 Jul 31.

PMID:
31362540
22.

Coronary Artery Disease and Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.

Faroux L, Guimaraes L, Wintzer-Wehekind J, Junquera L, Ferreira-Neto AN, Del Val D, Muntané-Carol G, Mohammadi S, Paradis JM, Rodés-Cabau J.

J Am Coll Cardiol. 2019 Jul 23;74(3):362-372. doi: 10.1016/j.jacc.2019.06.012. Review.

PMID:
31319919
23.

How does new-onset left bundle branch block affect the outcomes of transcatheter aortic valve repair?

Muntané-Carol G, Guimaraes L, Ferreira-Neto AN, Wintzer-Wehekind J, Junquera L, Del Val D, Faroux L, Philippon F, Rodés-Cabau J.

Expert Rev Med Devices. 2019 Jul;16(7):589-602. doi: 10.1080/17434440.2019.1624161. Epub 2019 Jun 7. Review.

PMID:
31172837
24.

Aortic Stenosis and Small Aortic Annulus.

Freitas-Ferraz AB, Tirado-Conte G, Dagenais F, Ruel M, Al-Atassi T, Dumont E, Mohammadi S, Bernier M, Pibarot P, Rodés-Cabau J.

Circulation. 2019 Jun 4;139(23):2685-2702. doi: 10.1161/CIRCULATIONAHA.118.038408. Epub 2019 Jun 3.

PMID:
31157994
25.

Long-Term Outcomes in Patients With New-Onset Persistent Left Bundle Branch Block Following TAVR.

Chamandi C, Barbanti M, Munoz-Garcia A, Latib A, Nombela-Franco L, Gutiérrez-Ibanez E, Veiga-Fernandez G, Cheema AN, Cruz-Gonzalez I, Serra V, Tamburino C, Mangieri A, Colombo A, Jiménez-Quevedo P, Elizaga J, Lee DH, Garcia Del Blanco B, Puri R, Côté M, Philippon F, Rodés-Cabau J.

JACC Cardiovasc Interv. 2019 Jun 24;12(12):1175-1184. doi: 10.1016/j.jcin.2019.03.025. Epub 2019 May 22.

PMID:
31129090
26.

Myocardial Fibrosis in Classical Low-Flow, Low-Gradient Aortic Stenosis.

Rosa VEE, Ribeiro HB, Sampaio RO, Morais TC, Rosa MEE, Pires LJT, Vieira MLC, Mathias W Jr, Rochitte CE, de Santis ASAL, Fernandes JRC, Accorsi TAD, Pomerantzeff PMA, Rodés-Cabau J, Pibarot P, Tarasoutchi F.

Circ Cardiovasc Imaging. 2019 May;12(5):e008353. doi: 10.1161/CIRCIMAGING.118.008353.

PMID:
31088148
27.

New-onset conduction disturbances: the last obstacle in the way of transcatheter aortic valve implantation.

Urena M, Rodés-Cabau J.

Eur Heart J. 2019 Jul 14;40(27):2228-2230. doi: 10.1093/eurheartj/ehz270. No abstract available.

PMID:
31071207
28.

Effect of Aortic Regurgitation by Cardiovascular Magnetic Resonance After Transcatheter Aortic Valve Implantation.

Ferreira-Neto AN, Merten C, Beurich HW, Zachow D, Richardt G, Larose E, Guimaraes L, Pibarot P, Pelletier-Beaumont E, Rodés-Cabau J, Abdel-Wahab M.

Am J Cardiol. 2019 Jul 1;124(1):78-84. doi: 10.1016/j.amjcard.2019.04.007. Epub 2019 Apr 9.

PMID:
31047652
29.

Intraprocedural high-degree atrioventricular block or complete heart block in transcatheter aortic valve replacement recipients with no prior intraventricular conduction disturbances.

Junquera L, Freitas-Ferraz AB, Padrón R, Silva I, Nunes Ferreira-Neto A, Guimaraes L, Mohammadi S, Morís C, Philippon F, Rodés-Cabau J.

Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28323. [Epub ahead of print]

PMID:
31037836
30.

Reply: Aortic Valve and Coronary Artery Disease in the TAVR Age: 2 Brothers With Independent Destinies.

Asmarats L, Vilalta V, Rodés-Cabau J.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):798-799. doi: 10.1016/j.jcin.2019.02.021. No abstract available.

PMID:
31000017
31.

Classical and Paradoxical Low-Flow, Low-Gradient Aortic Stenosis: The Evolving Role of TAVR.

Freitas-Ferraz AB, Rodés-Cabau J.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):764-766. doi: 10.1016/j.jcin.2019.02.022. No abstract available.

PMID:
31000013
32.

Tricuspid valve disease: diagnosis, prognosis and management of a rapidly evolving field.

Asmarats L, Taramasso M, Rodés-Cabau J.

Nat Rev Cardiol. 2019 Sep;16(9):538-554. doi: 10.1038/s41569-019-0186-1. Review.

PMID:
30988448
33.

Impact of moderate to severe mitral stenosis in patients undergoing transcatheter aortic valve replacement.

Fischer Q, Himbert D, Bernier M, Urena M, Nunes Ferreira-Neto A, Paradis JM, Mohammadi S, Iung B, Rodés-Cabau J.

Int J Cardiol. 2019 Jul 1;286:36-42. doi: 10.1016/j.ijcard.2019.03.053. Epub 2019 Mar 28.

PMID:
30967274
34.

Significant mitral regurgitation in patients undergoing TAVR: Mechanisms and imaging variables associated with improvement.

Chiche O, Rodés-Cabau J, Campelo-Parada F, Freitas-Ferraz AB, Regueiro A, Chamandi C, Rodriguez-Gabella T, Côté M, DeLarochellière R, Paradis JM, Dumont E, Doyle D, Mohammadi S, Bergeron S, Pibarot P, Beaudoin J.

Echocardiography. 2019 Apr;36(4):722-731. doi: 10.1111/echo.14303. Epub 2019 Mar 4.

PMID:
30834579
35.

Interatrial shunting for heart failure: current evidence and future perspectives.

Guimaraes L, Lindenfeld J, Sandoval J, Bayés-Genis A, Bernier M, Provencher S, Rodés-Cabau J.

EuroIntervention. 2019 Jun 20;15(2):164-171. doi: 10.4244/EIJ-D-18-01211.

36.

Impact of Discontinuation of Antithrombotic Therapy Following Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.

Wintzer-Wehekind J, Alperi A, Houde C, Côté JM, Guimaraes LFC, Côté M, Rodés-Cabau J.

Am J Cardiol. 2019 May 1;123(9):1538-1545. doi: 10.1016/j.amjcard.2019.01.043. Epub 2019 Feb 8.

PMID:
30792001
37.

Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.

Wintzer-Wehekind J, Alperi A, Houde C, Côté JM, Asmarats L, Côté M, Rodés-Cabau J.

J Am Coll Cardiol. 2019 Jan 29;73(3):278-287. doi: 10.1016/j.jacc.2018.10.061.

PMID:
30678757
38.

Long-term Outcomes Following Left Atrial Appendage Closure: Gaining Perspective on Non-pharmacological Stroke Prevention in Atrial Fibrillation.

Asmarats L, Rodés-Cabau J.

Rev Esp Cardiol (Engl Ed). 2019 Jun;72(6):440-442. doi: 10.1016/j.rec.2018.12.005. Epub 2019 Jan 19. English, Spanish. No abstract available.

PMID:
30670356
39.

Association of Clinical and Economic Outcomes With Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement.

Aljabbary T, Qiu F, Masih S, Fang J, Elbaz-Greener G, Austin PC, Rodés-Cabau J, Ko DT, Singh S, Wijeysundera HC.

JAMA Netw Open. 2018 May 18;1(1):e180088. doi: 10.1001/jamanetworkopen.2018.0088.

40.

Sex-Related Differences in Low-Gradient, Low-Ejection Fraction Aortic Stenosis: Results From the Multicenter TOPAS Study.

Bartko PE, Clavel MA, Annabi MS, Dahou A, Ristl R, Goliasch G, Baumgartner H, Hengstenberg C, Cavalcante JL, Burwash I, Enriquez-Sarano M, Bergler-Klein J, Rodés-Cabau J, Pibarot P, Mascherbauer J.

JACC Cardiovasc Imaging. 2019 Jan;12(1):203-205. doi: 10.1016/j.jcmg.2018.11.003. No abstract available.

PMID:
30621991
41.

Blood Disorders in Patients Undergoing Transcatheter Aortic Valve Replacement: A Review.

De Larochellière H, Puri R, Eikelboom JW, Rodés-Cabau J.

JACC Cardiovasc Interv. 2019 Jan 14;12(1):1-11. doi: 10.1016/j.jcin.2018.09.041. Review.

PMID:
30621965
42.

Transcatheter Mitral Valve Replacement With a New Supra-Annular Valve: First-in-Human Experience With the AltaValve System.

Nunes Ferreira-Neto A, Dagenais F, Bernier M, Dumont E, Freitas-Ferraz AB, Rodés-Cabau J.

JACC Cardiovasc Interv. 2019 Jan 28;12(2):208-209. doi: 10.1016/j.jcin.2018.10.056. Epub 2018 Dec 26. No abstract available.

PMID:
30594513
43.

Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry.

Taramasso M, Alessandrini H, Latib A, Asami M, Attinger-Toller A, Biasco L, Braun D, Brochet E, Connelly KA, Denti P, Deuschl F, Englmeier A, Fam N, Frerker C, Hausleiter J, Himbert D, Ho EC, Juliard JM, Kaple R, Kreidel F, Kuck KH, Ancona M, Lauten A, Lurz P, Mehr M, Nazif T, Nickening G, Pedrazzini G, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Schäfer U, Schofer J, Sievert H, Sievert K, Tang GHL, Tanner FC, Vahanian A, Webb JG, Windecker S, Yzeiray E, Zuber M, Maisano F, Leon MB, Hahn RT.

JACC Cardiovasc Interv. 2019 Jan 28;12(2):155-165. doi: 10.1016/j.jcin.2018.10.022. Epub 2018 Dec 26.

PMID:
30594510
44.

FORMA Tricuspid Repair System: device enhancements and initial experience.

Asmarats L, Philippon F, Bédard E, Rodés-Cabau J.

EuroIntervention. 2019 Mar 20;14(16):1656-1657. doi: 10.4244/EIJ-D-18-00956. No abstract available.

45.

Incidence, Clinical Characteristics, and Impact of Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement.

Vilalta V, Asmarats L, Ferreira-Neto AN, Maes F, de Freitas Campos Guimarães L, Couture T, Paradis JM, Mohammadi S, Dumont E, Kalavrouziotis D, Delarochellière R, Rodés-Cabau J.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):2523-2533. doi: 10.1016/j.jcin.2018.09.001.

PMID:
30573061
46.

Impact of Preexisting Left Bundle Branch Block in Transcatheter Aortic Valve Replacement Recipients.

Fischer Q, Himbert D, Webb JG, Eltchaninoff H, Muñoz-García AJ, Tamburino C, Nombela-Franco L, Nietlispach F, Moris C, Ruel M, Dager AE, Serra V, Cheema AN, Amat-Santos IJ, de Brito FS, Ribeiro H, Abizaid A, Sarmento-Leite R, Dumont E, Barbanti M, Durand E, Alonso Briales JH, Bouleti C, Immè S, Maisano F, Del Valle R, Miguel Benitez L, García Del Blanco B, Côté M, Philippon F, Urena M, Rodés-Cabau J.

Circ Cardiovasc Interv. 2018 Nov;11(11):e006927. doi: 10.1161/CIRCINTERVENTIONS.118.006927.

PMID:
30571207
47.

Transcarotid Compared With Other Alternative Access Routes for Transcatheter Aortic Valve Replacement.

Chamandi C, Abi-Akar R, Rodés-Cabau J, Blanchard D, Dumont E, Spaulding C, Doyle D, Pagny JY, DeLarochellière R, Lafont A, Paradis JM, Puri R, Karam N, Maes F, Rodriguez-Gabella T, Chassaing S, Le Page O, Kalavrouziotis D, Mohammadi S.

Circ Cardiovasc Interv. 2018 Nov;11(11):e006388. doi: 10.1161/CIRCINTERVENTIONS.118.006388.

PMID:
30571205
48.

Outcomes From Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis and Left Ventricular Ejection Fraction Less Than 30%: A Substudy From the TOPAS-TAVI Registry.

Maes F, Lerakis S, Barbosa Ribeiro H, Gilard M, Cavalcante JL, Makkar R, Herrmann HC, Windecker S, Enriquez-Sarano M, Cheema AN, Nombela-Franco L, Amat-Santos I, Muñoz-García AJ, Garcia Del Blanco B, Zajarias A, Lisko JC, Hayek S, Babaliaros V, Le Ven F, Gleason TG, Chakravarty T, Szeto W, Clavel MA, de Agustin A, Serra V, Schindler JT, Dahou A, Salah-Annabi M, Pelletier-Beaumont E, Côté M, Puri R, Pibarot P, Rodés-Cabau J.

JAMA Cardiol. 2019 Jan 1;4(1):64-70. doi: 10.1001/jamacardio.2018.4320.

PMID:
30566185
49.

Transcatheter aortic valve replacement: relative safety and efficacy of the procedure with different devices.

Del Val D, Ferreira-Neto AN, Asmarats L, Maes F, Guimaraes L, Junquera L, Wintzer J, Fischer Q, Barroso de Freitas Ferraz A, Puri R, Rodés-Cabau J.

Expert Rev Med Devices. 2019 Jan;16(1):11-24. doi: 10.1080/17434440.2019.1552132. Epub 2018 Dec 10. Review.

PMID:
30526139
50.

Reply: What Is the Value of Continuous Monitoring Post-Transcatheter Aortic Valve Replacement?

Rodés-Cabau J, Urena M, Pelletier-Beaumont E, Philippon F.

JACC Cardiovasc Interv. 2018 Nov 12;11(21):2235-2236. doi: 10.1016/j.jcin.2018.09.030. No abstract available.

PMID:
30409285

Supplemental Content

Loading ...
Support Center